PFCS
Pale Fire Capital SE Portfolio holdings
AUM $958M
1-Year Return
80.1%
This Quarter Return
-0.82%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$427M
AUM Growth
-$211M
(-33%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-40.71%
Top 10 Holdings %
Top 10 Hldgs %
94.19%
Holding
67
New
12
Increased
16
Reduced
16
Closed
16
Top Buys
| 1 |
B2Gold
BTG
|
+$86M |
| 2 |
uniQure
QURE
|
+$4.31M |
| 3 |
Aquestive Therapeutics
AQST
|
+$1.79M |
| 4 |
Shutterstock
SSTK
|
+$951K |
| 5 |
ATAI Life Sciences
ATAI
|
+$612K |
Top Sells
| 1 |
AT&T
T
|
+$211M |
| 2 |
Teladoc Health
TDOC
|
+$17.6M |
| 3 |
International Seaways
INSW
|
+$8.52M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$4.92M |
| 5 |
Dole
DOLE
|
+$4.72M |
Sector Composition
| 1 | Materials | 34.18% |
| 2 | Communication Services | 31.68% |
| 3 | Consumer Staples | 19.66% |
| 4 | Healthcare | 6.51% |
| 5 | Energy | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
B2Gold
BTG
$5.69B
| $128M | 29.02% |
52,419,026
+35,232,947
| +205% | +$86M |
|
2
Groupon
GRPN
$900M
| $124M | 28.07% |
10,181,070
| – | – |
|
|
3
Dole
DOLE
$1.3B
| $83.9M | 19.04% |
6,198,640
-348,843
| -5% | -$4.72M |
|
|
4
International Seaways
INSW
$2.39B
| $18.6M | 4.22% |
517,264
-237,151
| -31% | -$8.52M |
|
|
CGAU
5
Centerra Gold
CGAU
$1.85B
| $12.9M | 2.93% |
2,272,798
+56,388
| +3% | +$321K |
|
|
6
uniQure
QURE
$802M
| $10.3M | 2.33% |
580,708
+244,240
| +73% | +$4.31M |
|
|
TEN
7
Tsakos Energy Navigation Ltd.
TEN
$694M
| $8.31M | 1.89% |
479,288
-25,110
| -5% | -$435K |
|
8
Angi Inc
ANGI
$774M
| $7.71M | 1.75% |
464,202
-75,308
| -14% | -$1.25M |
|
|
IAUX
9
i-80 Gold Corp
IAUX
$709M
| $4.94M | 1.12% |
10,179,770
+290,201
| +3% | +$141K |
|
|
10
Shutterstock
SSTK
$781M
| $3.86M | 0.88% |
127,151
+31,341
| +33% | +$951K |
|
11
Ocular Therapeutix
OCUL
$2.17B
| $3.8M | 0.86% |
444,813
+6,613
| +2% | +$56.5K |
|
12
Navios Maritime Partners
NMM
$1.4B
| $3.65M | 0.83% |
84,351
-85,875
| -50% | -$3.72M |
|
|
CIM
13
Chimera Investment
CIM
$1.14B
| $2.09M | 0.47% |
149,191
-190,282
| -56% | -$2.66M |
|
|
14
Aquestive Therapeutics
AQST
$600M
| $1.87M | 0.42% |
525,756
+501,756
| +2,091% | +$1.79M |
|
15
Mineralys Therapeutics
MLYS
$2.91B
| $1.69M | 0.38% |
136,897
| – | – |
|
16
Adverum Biotechnologies
ADVM
$63.6M
| $1.47M | 0.33% |
315,154
+6,783
| +2% | +$31.7K |
|
17
Caribou Biosciences
CRBU
$169M
| $1.17M | 0.26% |
734,204
-700
| -0.1% | -$1.11K |
|
18
X4 Pharmaceuticals
XFOR
$71.6M
| $1.03M | 0.23% |
46,732
-6,694
| -13% | -$147K |
|
|
19
Teladoc Health
TDOC
$1.4B
| $1.01M | 0.23% |
111,452
-1,935,871
| -95% | -$17.6M |
|
20
Scorpio Tankers
STNG
$3.11B
| $757K | 0.17% |
15,232
-30,078
| -66% | -$1.49M |
|
|
21
ATAI Life Sciences
ATAI
$992M
| $662K | 0.15% |
497,402
+460,018
| +1,231% | +$612K |
|
|
INZY
22
DELISTED
Inozyme Pharma
INZY
| $605K | 0.14% |
218,537
+30,000
| +16% | +$83.1K |
|
|
CYBN
23
Cybin
CYBN
$144M
| $537K | 0.12% |
+60,912
| New | +$537K |
|
|
CMRX
24
DELISTED
Chimerix, Inc.
CMRX
| $371K | 0.08% |
106,531
-148,432
| -58% | -$517K |
|
|
MITT
25
AG Mortgage Investment Trust
MITT
$248M
| $340K | 0.08% |
51,202
-82,069
| -62% | -$546K |
|